Literature DB >> 26433728

Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma.

Harunobu Sato1, Kunihiro Toyama2, Yoshikazu Koide2, Shinji Ozeki2, Kouhei Hatta2, Kotaro Maeda2.   

Abstract

PURPOSE: We devised a simple dichotomous classification system and showed sufficient reproducibility to indicate treatment strategies for peritoneal metastasis of colorectal cancer.
METHODS: We included 67 patients with peritoneal metastasis of colorectal cancer and classified them according to the largest lesion size, number of lesions and number of regional peritoneal metastases. The oncological data were recorded and compared.
RESULTS: According to the univariate analyses, the prognoses were significantly better in patients with ≤3 disseminated lesions than in those with ≥4, and in patients with disseminated lesions in only one region than in those with ≥2 lesions. A multivariate analysis showed that primary tumor resection and the presence of peritoneal metastases in only one region were favorable factors for the patient survival. Patients with disseminated lesions in only one region (localized group) and those with nonlocalized lesions had three-year survival rates of 45.6 and 12.2 %, respectively. Finally, primary tumor resection improved the prognoses in both the localized and nonlocalized groups.
CONCLUSIONS: Colorectal cancer patients were categorized into localized and nonlocalized groups according to the number of regions with peritoneal metastasis, and significant prognostic associations were demonstrated. Subsequent analyses of the oncological data suggested that primary tumor resection contributes to an improved prognosis in all patients with synchronous peritoneal metastases.

Entities:  

Keywords:  Colorectal cancer; Peritoneal metastases; Prognosis; Survival rate

Mesh:

Year:  2015        PMID: 26433728     DOI: 10.1007/s00595-015-1254-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

Authors:  Jan Franko; Qian Shi; Charles D Goldman; Barbara A Pockaj; Garth D Nelson; Richard M Goldberg; Henry C Pitot; Axel Grothey; Steven R Alberts; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.

Authors:  Yasuhiro Inoue; Takashi Iwata; Yoshinaga Okugawa; Aya Kawamoto; Junichiro Hiro; Yuji Toiyama; Koji Tanaka; Keiichi Uchida; Yasuhiko Mohri; Chikao Miki; Masato Kusunoki
Journal:  Oncology       Date:  2012-11-09       Impact factor: 2.935

3.  A statistical analysis of the relationship of physical status to postoperative mortality in 68,388 cases.

Authors:  C J Vacanti; R J VanHouten; R C Hill
Journal:  Anesth Analg       Date:  1970 Jul-Aug       Impact factor: 5.108

4.  Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.

Authors:  S R Pestieau; P H Sugarbaker
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Authors:  Jan Franko; Zuhaib Ibrahim; Niraj J Gusani; Matthew P Holtzman; David L Bartlett; Herbert J Zeh
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Validation and clinical use of the Japanese classification of colorectal carcinomatosis: benefit of surgical cytoreduction even without hyperthermic intraperitoneal chemotherapy.

Authors:  Hirotoshi Kobayashi; Masayuki Enomoto; Tetsuro Higuchi; Hiroyuki Uetake; Satoru Iida; Toshiaki Ishikawa; Megumi Ishiguro; Kenichi Sugihara
Journal:  Dig Surg       Date:  2010-11-10       Impact factor: 2.588

7.  Use of surgery among elderly patients with stage IV colorectal cancer.

Authors:  Larissa K F Temple; Lillian Hsieh; W Douglas Wong; Leonard Saltz; Deborah Schrag
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

8.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

9.  Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon.

Authors:  Sotaro Sadahiro; Toshiyuki Suzuki; Yuji Maeda; Akira Tanaka; Hiroyasu Makuuchi; Akemi Kamijo; Yasuo Haruki; Chieko Murayama
Journal:  J Gastrointest Surg       Date:  2009-06-02       Impact factor: 3.452

10.  Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer.

Authors:  Yuji Miyamoto; Masayuki Watanabe; Yasuo Sakamoto; Hironobu Shigaki; Asuka Murata; Hidetaka Sugihara; Kojiro Etoh; Takatsugu Ishimoto; Masaaki Iwatsuki; Yoshifumi Baba; Shiro Iwagami; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-03-14       Impact factor: 2.549

View more
  2 in total

1.  Risk Factors for Synchronous Peritoneal Metastases in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuanxin Zhang; Xiusen Qin; Rui Luo; Hui Wang; Huaiming Wang; Hongzhi Luo
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

2.  Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.

Authors:  Zifeng Yang; Yong Li; Xiusen Qin; Zejian Lv; Huaiming Wang; Deqing Wu; Zixu Yuan; Hui Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.